Abstract:Ferroptosis is a novel form of programmed cell death characterized by iron-dependent lipid peroxidation accumulation. It is morphologically, biochemically, and genetically distinct from other known cell death, such as apoptosis, necrosis, and pyroptosis. Its regulatory mechanisms include iron metabolism, fatty acid metabolism, mitochondrial respiration, and antioxidative systems eliminating lipid peroxidation, such as glutathione synthesis, selenium-dependent glutathione peroxidase 4, and ubiquinone. The disruption of cellular redox systems causes damage to the cellular membrane leading to ferroptotic cell death. Recent studies have shown that numerous pathological diseases, like tumors, neurodegenerative disorders, and ischemia-reperfusion injury are associated with ferroptosis. As such, pharmacological regulation of ferroptosis either by activation or by suppression will provide a vast potential for treatments of relevant diseases. This review will discuss the advanced progress in ferroptosis and its regulatory mechanisms from both the antioxidative and oxidative sides. In addition, the roles of ferroptosis in various tumorigenesis, development, and therapeutic strategies will be addressed, particularly to chemotherapy and immunotherapy, as well as the discoveries from Traditional Chinese Medicine. This review will lead us to have a comprehensive understanding of the future exploration of ferroptosis and cancer therapy.

Nucleolar Stress Promotes and Cooperates with Ferroptosis to Suppress Cancer Growth

Targeting Ferroptosis in Breast Cancer

Ferroptosis as a potential target for cancer therapy

Crosstalk Between Ferroptosis and Stress—implications in Cancer Therapeutic Responses

Ferroptosis and its emerging role in tumor

The function and mechanism of ferroptosis in cancer

Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy

p53 in ferroptosis regulation: the new weapon for the old guardian

p53: A double-edged sword in tumor ferroptosis

Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs

The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy

Cooperation Effects of Radiation and Ferroptosis on Tumor Suppression and Radiation Injury

The crosstalk between oncogenic signaling and ferroptosis in cancer

Ferroptosis is an effective strategy for cancer therapy

Ferroptosis in Cancer Progression: Role of Noncoding RNAs

Ferroptosis and the bidirectional regulatory factor p53

Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer

The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer

Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy

The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity

Ferroptosis as a p53-mediated activity during tumour suppression